Evidence map›Paper›PMID 32731000›Full record

ArticleThe Journal of infection2021

Comorbidities for fatal outcome among the COVID-19 patients: A hospital-based case-control study.

Qing-Bin Lu, Wan-Li Jiang, Xin Zhang, Hui-Jun Li, Xiao-Ai Zhang, Hao-Long Zeng, Juan Du, Guo-Liang Yang, Lei-Ke Zhang, Rui Li and 3 more

Abstract readLetterComment

PubMed Full text at PMC Publisher

In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it

0cells of the map it votes in

11citing papers in PubMed, 2 pooled it

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
Pooled it
Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis.Diabetes & metabolic syndrome
Pooled it
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.Scientific reports · 2024
Article
The path to healthy ageing in China: a Peking University-Lancet Commission.Lancet (London, England) · 2022
Review
Decline of onset-to-diagnosis interval and its impacts on clinical outcome of COVID-19 in China: a nation-wide observational study.BMC infectious diseases · 2022
Observational
Pre-medication with oral anticoagulants is associated with better outcomes in a large multinational COVID-19 cohort with cardiovascular comorbidities.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
Article
Clinical Characteristics and Predictors of Mortality in Elderly Patients Hospitalized with COVID-19 in Bangladesh: A Multicenter, Retrospective Study.Interdisciplinary perspectives on infectious diseases · 2022
Article
Archivos de bronconeumologia · 2021
Article
Therapeutic Intervention of COVID-19 by Natural Products: A Population-Specific Survey Directed Approach.Molecules (Basel, Switzerland) · 2021
Review
Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension.Cell discovery · 2020
Article
Total costs of inpatient treatment for COVID-19 in a tertiary hospital in Serbia.Hippokratia
Article

4 · The record

Corrections and comments

Comment on
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study.2020

5 · Who and what money

Authors and funding

13 authors.

Qing-Bin LuDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, P. R China.

Wan-Li JiangRenmin Hospital of Wuhan University, Wuhan, P. R China.

Xin ZhangHuangmei People's Hospital, Huanggang, P. R. China.

Hui-Jun LiTongji Hospital of Huazhong University of Science and Technology, Wuhan, P. R. China.

Xiao-Ai ZhangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China.

Hao-Long ZengTongji Hospital of Huazhong University of Science and Technology, Wuhan, P. R. China.

Juan DuDepartment of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, P. R China.

Guo-Liang YangJinan Center for Disease Control and Prevention, P. R China.

Lei-Ke ZhangState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, P. R. China.

Rui LiSchool of Health Sciences, Wuhan University, Wuhan, P. R. China.

Li-Qun FangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: fang_lq@163.com.

Hao LiState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: lihao_1986@126.com.

Wei LiuState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China. Electronic address: liuwei@bmi.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Case-Control StudiesCohort StudiesComorbidityCritical CareFatal OutcomeHospitalsHumansRisk FactorsSARS-CoV-2AntihypertensionComorbidityCOVID-19OutcomeRisk factorSARS-CoV-2

Identifiers

PMID32731000

DOI10.1016/j.jinf.2020.07.026

PMCPMC7384426

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.